NRXS

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Neuraxis, Inc.

NYSE MKT | NRXS

3.44

USD

$0.00

(

0.00%

)

At Close (As of Oct 24, 2025)

$37.71M

Market Cap

-

P/E Ratio

-1.05

EPS

$3.99

52 Week High

$1.33

52 Week Low

HEALTHCARE

Sector

NRXS Chart

Recent Chart
Price Action

NRXS Technicals

Tags:

NRXS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $2.3M
Total Revenue $2.7M
Cost Of Revenue $362K
Costof Goods And Services Sold $362K
Operating Income -$7.2M
Selling General And Administrative $8.9M
Research And Development $206K
Operating Expenses $9.5M
Investment Income Net -
Net Interest Income -$532K
Interest Income -
Interest Expense $301K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $38K
Income Before Tax -$8.2M
Income Tax Expense -$8.2M
Interest And Debt Expense -
Net Income From Continuing Operations -$8.2M
Comprehensive Income Net Of Tax -
Ebit -$7.9M
Ebitda -$7.9M
Net Income -$8.2M

Revenue & Profitability

Earnings Performance

NRXS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $4.8M
Total Current Assets $4.3M
Cash And Cash Equivalents At Carrying Value $3.7M
Cash And Short Term Investments $3.7M
Inventory $44K
Current Net Receivables $245K
Total Non Current Assets $491K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $97K
Intangible Assets Excluding Goodwill $97K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $280K
Other Non Current Assets -
Total Liabilities $2.7M
Total Current Liabilities $2.4M
Current Accounts Payable $597K
Deferred Revenue -
Current Debt -
Short Term Debt $217K
Total Non Current Liabilities $256K
Capital Lease Obligations $319K
Long Term Debt -
Current Long Term Debt $154K
Long Term Debt Noncurrent -
Short Long Term Debt Total $473K
Other Current Liabilities $1.6M
Other Non Current Liabilities -
Total Shareholder Equity $2.1M
Treasury Stock -
Retained Earnings -$57M
Common Stock $7K
Common Stock Shares Outstanding $6.9M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$6.1M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $38K
Capital Expenditures $28K
Change In Receivables -
Change In Inventory -$33K
Profit Loss -
Cashflow From Investment -$28K
Cashflow From Financing $9.7M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$8.2M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $2.3M
Total Revenue $2.7M
Cost Of Revenue $362K
Costof Goods And Services Sold $362K
Operating Income -$7.2M
Selling General And Administrative $8.9M
Research And Development $206K
Operating Expenses $9.5M
Investment Income Net -
Net Interest Income -$532K
Interest Income -
Interest Expense $301K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $38K
Income Before Tax -$8.2M
Income Tax Expense -$8.2M
Interest And Debt Expense -
Net Income From Continuing Operations -$8.2M
Comprehensive Income Net Of Tax -
Ebit -$7.9M
Ebitda -$7.9M
Net Income -$8.2M

NRXS Profile

Neuraxis, Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Neuraxis, Inc. is a pioneering medical technology company headquartered in Versailles, Indiana, focused on the development and commercialization of advanced neuromodulation therapy devices for various neurological conditions. With a strong emphasis on innovation, the company utilizes state-of-the-art technology and research to create therapeutic solutions that significantly enhance patient outcomes and overall quality of life. Neuraxis's dedication to meeting unmet medical needs positions it for substantial growth and influence within the rapidly evolving neuromodulation market, making it a compelling opportunity for institutional investors.

BYND
-25.80%
$2.10
WGRX
+175.50%
$1.11
TOVX
+1.63%
$0.34
VIVK
+11.91%
$0.29
YYAI
-14.98%
$0.07
F
+12.07%
$13.83
YDKG
-15.04%
$0.06
INTC
+0.62%
$38.40
BURU
+15.68%
$0.39
CGBS
-39.47%
$0.03
CENN
-5.04%
$0.20
DVLT
+43.15%
$3.22
VHAI
0.00%
$0.00
ASST
+27.28%
$1.10
NVDA
+2.48%
$186.68
BITF
+10.68%
$4.61
ADAP
-3.44%
$0.07
AAL
+7.90%
$13.78
MSAI
+101.73%
$1.35
TSLA
-3.39%
$433.72
RGTI
-1.90%
$38.84
NEUP
+54.07%
$6.24
T
+2.21%
$25.16
DNN
+2.56%
$2.80
ADTX
-26.38%
$0.22
NOK
+1.94%
$6.29
SCNX
-39.61%
$1.57
RIG
+0.77%
$3.92
AMD
+7.63%
$252.92
PLUG
+2.58%
$2.95
AXDX
-61.36%
$0.03
ABEV
-1.13%
$2.18
QBTS
+5.15%
$32.65
RF
+1.95%
$24.57
SMCI
-8.72%
$47.92
LAES
+22.55%
$7.01
GPUS
+5.23%
$0.40
GRAB
+1.77%
$5.72
QLGN
+3.11%
$3.64
ONDS
+5.66%
$7.46
TLRY
+0.67%
$1.49
SNAP
+1.01%
$7.95
SOFI
+3.93%
$29.18
NUAI
+54.20%
$6.09
CIFR
+19.73%
$20.66
BBD
+1.51%
$3.35
CAN
+7.38%
$1.89
QS
+14.22%
$16.74
AIRE
-22.42%
$0.76
ETHD
-3.40%
$3.83
WTO
-8.60%
$0.06
ACHR
+3.52%
$11.29
RMBL
+60.50%
$3.21
IONZ
-3.76%
$3.83
ADD
-25.47%
$0.05
CJET
+18.72%
$0.10
VLY
+4.24%
$10.56
QUBT
-2.57%
$15.53
JOBY
+3.24%
$16.17
IREN
+12.60%
$62.90
RXRX
+5.58%
$6.05
RR
+12.17%
$6.08
AMC
-1.64%
$2.68
SRM
+53.27%
$10.30
NVTS
+3.37%
$14.07
PLTR
+2.29%
$184.63
BTBT
+4.97%
$3.90
CLOV
+19.37%
$3.82
UUUU
+0.47%
$21.36
BTG
-0.47%
$5.20
AAPL
+0.43%
$259.58
AMZN
+1.53%
$224.48
DFLI
+14.15%
$1.29
NIO
+0.58%
$6.93
MARA
+1.66%
$19.54
CUTR
-10.19%
$0.09
APLD
+0.14%
$33.43
PBR
-0.84%
$11.74
NAKA
+5.66%
$0.84
WU
+10.13%
$8.96
WLGS
-5.57%
$0.04
SOUN
-1.42%
$17.98
VZ
+1.14%
$38.84
ETWO
0.00%
$3.30
RVPH
+17.40%
$0.66
RIVN
-0.67%
$13.00
LAZR
+28.99%
$2.18
RGTZ
-0.06%
$14.89
SMR
+0.37%
$37.70
IVZ
+1.43%
$23.00
AFMD
-34.94%
$0.18
ERIC
-0.31%
$9.44
IONQ
+1.94%
$60.52
KDLY
+10.41%
$0.79
ELBM
+3.61%
$1.72
EONR
-15.10%
$0.53
PFE
+0.44%
$24.78
BAC
+1.55%
$52.56
WULF
+5.67%
$13.61
NEM
-6.27%
$83.33
BYND
-25.80%
$2.10
WGRX
+175.50%
$1.11
TOVX
+1.63%
$0.34
VIVK
+11.91%
$0.29
YYAI
-14.98%
$0.07
F
+12.07%
$13.83
YDKG
-15.04%
$0.06
INTC
+0.62%
$38.40
BURU
+15.68%
$0.39
CGBS
-39.47%
$0.03
CENN
-5.04%
$0.20
DVLT
+43.15%
$3.22
VHAI
0.00%
$0.00
ASST
+27.28%
$1.10
NVDA
+2.48%
$186.68
BITF
+10.68%
$4.61
ADAP
-3.44%
$0.07
AAL
+7.90%
$13.78
MSAI
+101.73%
$1.35
TSLA
-3.39%
$433.72
RGTI
-1.90%
$38.84
NEUP
+54.07%
$6.24
T
+2.21%
$25.16
DNN
+2.56%
$2.80
ADTX
-26.38%
$0.22
NOK
+1.94%
$6.29
SCNX
-39.61%
$1.57
RIG
+0.77%
$3.92
AMD
+7.63%
$252.92
PLUG
+2.58%
$2.95
AXDX
-61.36%
$0.03
ABEV
-1.13%
$2.18
QBTS
+5.15%
$32.65
RF
+1.95%
$24.57
SMCI
-8.72%
$47.92
LAES
+22.55%
$7.01
GPUS
+5.23%
$0.40
GRAB
+1.77%
$5.72
QLGN
+3.11%
$3.64
ONDS
+5.66%
$7.46
TLRY
+0.67%
$1.49
SNAP
+1.01%
$7.95
SOFI
+3.93%
$29.18
NUAI
+54.20%
$6.09
CIFR
+19.73%
$20.66
BBD
+1.51%
$3.35
CAN
+7.38%
$1.89
QS
+14.22%
$16.74
AIRE
-22.42%
$0.76
ETHD
-3.40%
$3.83
WTO
-8.60%
$0.06
ACHR
+3.52%
$11.29
RMBL
+60.50%
$3.21
IONZ
-3.76%
$3.83
ADD
-25.47%
$0.05
CJET
+18.72%
$0.10
VLY
+4.24%
$10.56
QUBT
-2.57%
$15.53
JOBY
+3.24%
$16.17
IREN
+12.60%
$62.90
RXRX
+5.58%
$6.05
RR
+12.17%
$6.08
AMC
-1.64%
$2.68
SRM
+53.27%
$10.30
NVTS
+3.37%
$14.07
PLTR
+2.29%
$184.63
BTBT
+4.97%
$3.90
CLOV
+19.37%
$3.82
UUUU
+0.47%
$21.36
BTG
-0.47%
$5.20
AAPL
+0.43%
$259.58
AMZN
+1.53%
$224.48
DFLI
+14.15%
$1.29
NIO
+0.58%
$6.93
MARA
+1.66%
$19.54
CUTR
-10.19%
$0.09
APLD
+0.14%
$33.43
PBR
-0.84%
$11.74
NAKA
+5.66%
$0.84
WU
+10.13%
$8.96
WLGS
-5.57%
$0.04
SOUN
-1.42%
$17.98
VZ
+1.14%
$38.84
ETWO
0.00%
$3.30
RVPH
+17.40%
$0.66
RIVN
-0.67%
$13.00
LAZR
+28.99%
$2.18
RGTZ
-0.06%
$14.89
SMR
+0.37%
$37.70
IVZ
+1.43%
$23.00
AFMD
-34.94%
$0.18
ERIC
-0.31%
$9.44
IONQ
+1.94%
$60.52
KDLY
+10.41%
$0.79
ELBM
+3.61%
$1.72
EONR
-15.10%
$0.53
PFE
+0.44%
$24.78
BAC
+1.55%
$52.56
WULF
+5.67%
$13.61
NEM
-6.27%
$83.33
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.